Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.09 HKD
696.61 M HKD
80.44 B HKD
About China National Accord Medicines Corporation Ltd Class A
Sector
Industry
CEO
Jin Xiong Li
Website
Headquarters
Shenzhen
Founded
1985
ISIN
CNE0000009M8
FIGI
BBG000BZF7H9
China National Accord Medicines Corp. Ltd. engages in the research, development, and consultation services of pharmaceutical packaging materials and pharmaceutical industry products. It operates through the following segments: Pharmaceutical Distribution, and Pharmaceutical Retail. The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics. The Pharmaceutical Retail segment manufactures and sells medicine. The company was founded in May 1985 and is headquartered in Shenzhen, China.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 200028 is 13.48 HKD — it hasn't changed in the past 24 hours. Watch China National Accord Medicines Corporation Ltd Class B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange China National Accord Medicines Corporation Ltd Class B stocks are traded under the ticker 200028.
200028 stock has fallen by −0.44% compared to the previous week, the month change is a −1.25% fall, over the last year China National Accord Medicines Corporation Ltd Class B has showed a 3.06% increase.
We've gathered analysts' opinions on China National Accord Medicines Corporation Ltd Class B future price: according to them, 200028 price has a max estimate of 35.10 HKD and a min estimate of 21.30 HKD. Watch 200028 chart and read a more detailed China National Accord Medicines Corporation Ltd Class B stock forecast: see what analysts think of China National Accord Medicines Corporation Ltd Class B and suggest that you do with its stocks.
200028 reached its all-time high on Apr 14, 2015 with the price of 47.69 HKD, and its all-time low was 1.55 HKD and was reached on Oct 31, 2005. View more price dynamics on 200028 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
200028 stock is 0.45% volatile and has beta coefficient of 0.76. Track China National Accord Medicines Corporation Ltd Class B stock price on the chart and check out the list of the most volatile stocks — is China National Accord Medicines Corporation Ltd Class B there?
Today China National Accord Medicines Corporation Ltd Class B has the market capitalization of 7.51 B, it has decreased by −0.06% over the last week.
Yes, you can track China National Accord Medicines Corporation Ltd Class B financials in yearly and quarterly reports right on TradingView.
China National Accord Medicines Corporation Ltd Class B is going to release the next earnings report on Oct 23, 2025. Keep track of upcoming events with our Earnings Calendar.
200028 earnings for the last quarter are 0.61 HKD per share, whereas the estimation was 0.61 HKD resulting in a 0.00% surprise. The estimated earnings for the next quarter are 0.67 HKD per share. See more details about China National Accord Medicines Corporation Ltd Class B earnings.
China National Accord Medicines Corporation Ltd Class B revenue for the last quarter amounts to 20.28 B HKD, despite the estimated figure of 27.00 B HKD. In the next quarter, revenue is expected to reach 29.11 B HKD.
200028 net income for the last quarter is 364.63 M HKD, while the quarter before that showed 350.69 M HKD of net income which accounts for 3.98% change. Track more China National Accord Medicines Corporation Ltd Class B financial stats to get the full picture.
Yes, 200028 dividends are paid annually. The last dividend per share was 0.40 HKD. As of today, Dividend Yield (TTM)% is 2.96%. Tracking China National Accord Medicines Corporation Ltd Class B dividends might help you take more informed decisions.
China National Accord Medicines Corporation Ltd Class B dividend yield was 2.77% in 2024, and payout ratio reached 31.71%. The year before the numbers were 5.59% and 23.67% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 26, 2025, the company has 34.83 K employees. See our rating of the largest employees — is China National Accord Medicines Corporation Ltd Class B on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. China National Accord Medicines Corporation Ltd Class B EBITDA is 2.38 B HKD, and current EBITDA margin is 4.38%. See more stats in China National Accord Medicines Corporation Ltd Class B financial statements.
Like other stocks, 200028 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade China National Accord Medicines Corporation Ltd Class B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So China National Accord Medicines Corporation Ltd Class B technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating China National Accord Medicines Corporation Ltd Class B stock shows the sell signal. See more of China National Accord Medicines Corporation Ltd Class B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.